Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
docetaxel (taxotere) (1 trial)
gemcitabine (gemzar) (1 trial)
Sarcoma (Phase 3)
Trials (1 total)
Trial APIs (2 total)